Identification of crucial genes involved in thyroid cancer development
- PMID: 37211566
- DOI: 10.1186/s43046-023-00177-0
Identification of crucial genes involved in thyroid cancer development
Abstract
Background: A malignancy of the endocrine system, one of the most common types, is thyroid cancer. It is proven that children who receive radiation treatment for leukemia or lymphoma are at a heightened risk of thyroid cancer due to low-dose radiation exposure throughout childhood. Several factors can increase the risk of thyroid cancer (ThyCa), such as chromosomal and genetic mutations, iodine intake, TSH levels, autoimmune thyroid disorders, estrogen, obesity, lifestyle changes, and environmental contaminants.
Objectives: The study aimed to identify a specific gene as an essential candidate for thyroid cancer progression. We might be able to focus on developing a better understanding of how thyroid cancer is inherited.
Methods: The review article uses electronic databases such as PubMed, Google Scholar, Ovid MEDLINE, Embase, and Cochrane Central. The most frequently associated genes with thyroid cancer found on PubMed were BAX, XRCC1, XRCC3, XPO5, IL-10, BRAF, RET, and K-RAS. To perform an electronic literature search, genes derived from DisGeNET: a database of gene-disease associations, including PRKAR1A, BRAF, RET, NRAS, and KRAS, are used.
Conclusion: Examining the genetics of thyroid cancer explicitly emphasizes the primary genes associated with the pathophysiology of young and older people with thyroid cancer. Developing such gene investigations at the beginning of the thyroid cancer development process can identify better outcomes and the most aggressive thyroid cancers.
Keywords: Aging process; Genetics; Molecular mechanisms; Pathogenesis; Thyroid carcinoma.
© 2023. The Author(s).
Similar articles
-
Concomitant RAS, RET/PTC, or BRAF mutations in advanced stage of papillary thyroid carcinoma.Thyroid. 2014 Aug;24(8):1256-66. doi: 10.1089/thy.2013.0610. Epub 2014 Jun 10. Thyroid. 2014. PMID: 24798740 Free PMC article.
-
Genetic alterations of differentiated thyroid carcinoma in iodine-rich and iodine-deficient countries.Cancer Med. 2016 Aug;5(8):1883-9. doi: 10.1002/cam4.781. Epub 2016 Jun 5. Cancer Med. 2016. PMID: 27264674 Free PMC article.
-
Mutational screening of RET, HRAS, KRAS, NRAS, BRAF, AKT1, and CTNNB1 in medullary thyroid carcinoma.Anticancer Res. 2011 Dec;31(12):4179-83. Anticancer Res. 2011. PMID: 22199277
-
Molecular events in follicular thyroid tumors.Cancer Treat Res. 2004;122:85-105. doi: 10.1007/1-4020-8107-3_4. Cancer Treat Res. 2004. PMID: 16209039 Review.
-
Evidence that one subset of anaplastic thyroid carcinomas are derived from papillary carcinomas due to BRAF and p53 mutations.Cancer. 2005 Jun 1;103(11):2261-8. doi: 10.1002/cncr.21073. Cancer. 2005. PMID: 15880523 Review.
Cited by
-
NOS3 Gene Polymorphisms (rs2070744 and rs1799983) and Differentiated Thyroid Cancer: Investigating Associations with Clinical Outcomes.Int J Mol Sci. 2025 Jan 17;26(2):759. doi: 10.3390/ijms26020759. Int J Mol Sci. 2025. PMID: 39859471 Free PMC article.
-
Germline polymorphisms of the NOD2 pathway may predict the effectiveness of radioiodine in differentiated thyroid cancer treatment.J Endocrinol Invest. 2024 Dec;47(12):2969-2980. doi: 10.1007/s40618-024-02389-0. Epub 2024 May 16. J Endocrinol Invest. 2024. PMID: 38755492 Free PMC article.
-
Bridging the deficit: Assessing knowledge gaps in thyroid cancer management amongst physicians in the Democratic Republic of Congo.World J Clin Oncol. 2025 Jul 24;16(7):107495. doi: 10.5306/wjco.v16.i7.107495. World J Clin Oncol. 2025. PMID: 40741193 Free PMC article.
-
Systems biology approach delineates critical pathways associated with papillary thyroid cancer: a multi-omics data analysis.Thyroid Res. 2025 Apr 11;18(1):15. doi: 10.1186/s13044-025-00230-1. Thyroid Res. 2025. PMID: 40211357 Free PMC article.
References
-
- McDow AD, Pitt SC. Extent of surgery for low-risk differentiated thyroid cancer. Surg Clin. 2019;99(4):599–610.
-
- Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7–30.
-
- Henley SJ, Ward EM, Scott S, Ma J, Anderson RN, Firth AU, Thomas CC, Islami F, Weir HK, Lewis DR, Sherman RL, Wu M, Benard VB, Richardson LC, Jemal A, Cronin K, Kohler BA. Annual report to the nation on the status of cancer, part I: National cancer statistics. Cancer. 2020;126(10):2225–49. - PubMed - DOI
-
- Bhatti P, Veiga LH, Ronckers CM, Sigurdson AJ, Stovall M, Smith SA, Weathers R, Leisenring W, Mertens AC, Hammond S, Friedman DL. Risk of second primary thyroid cancer after radiotherapy for a childhood cancer in a large cohort study: an update from the childhood cancer survivor study. Radiat Res. 2010;174(6a):741–52. - PubMed - DOI - PMC
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials
Miscellaneous